154 related articles for article (PubMed ID: 37068384)
21. Synthesis and biological evaluation of structurally diverse 6-aryl-3-aroyl-indole analogues as inhibitors of tubulin polymerization.
Ren W; Deng Y; Ward JD; Vairin R; Bai R; Wanniarachchi HI; Hamal KB; Tankoano PE; Tamminga CS; Bueno LMA; Hamel E; Mason RP; Trawick ML; Pinney KG
Eur J Med Chem; 2024 Jan; 263():115794. PubMed ID: 37984295
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and Biological Evaluation of New Antitubulin Agents Containing 2-(3',4',5'-trimethoxyanilino)-3,6-disubstituted-4,5,6,7-tetrahydrothieno[2,3-
Romagnoli R; Prencipe F; Oliva P; Cacciari B; Balzarini J; Liekens S; Hamel E; Brancale A; Ferla S; Manfredini S; Zurlo M; Finotti A; Gambari R
Molecules; 2020 Apr; 25(7):. PubMed ID: 32272719
[TBL] [Abstract][Full Text] [Related]
23. Design, synthesis and evaluation of novel bis-substituted aromatic amide dithiocarbamate derivatives as colchicine site tubulin polymerization inhibitors with potent anticancer activities.
Sun YX; Song J; Kong LJ; Sha BB; Tian XY; Liu XJ; Hu T; Chen P; Zhang SY
Eur J Med Chem; 2022 Feb; 229():114069. PubMed ID: 34971875
[TBL] [Abstract][Full Text] [Related]
24. Synthesis of Combretastatin-A4 Carboxamidest that Mimic Sulfonyl Piperazines by a Molecular Hybridization Approach: in vitro Cytotoxicity Evaluation and Inhibition of Tubulin Polymerization.
Jadala C; Sathish M; Anchi P; Tokala R; Lakshmi UJ; Reddy VG; Shankaraiah N; Godugu C; Kamal A
ChemMedChem; 2019 Dec; 14(24):2052-2060. PubMed ID: 31674147
[TBL] [Abstract][Full Text] [Related]
25. Discovery of novel 2-(trifluoromethyl)quinolin-4-amine derivatives as potent antitumor agents with microtubule polymerization inhibitory activity.
Liu K; Mo M; Yu G; Yu J; Song SM; Cheng S; Li HM; Meng XL; Zeng XP; Xu GC; Luo H; Xu BX
Bioorg Chem; 2023 Oct; 139():106727. PubMed ID: 37451147
[TBL] [Abstract][Full Text] [Related]
26. Tubulin inhibitors: Discovery of a new scaffold targeting extra-binding residues within the colchicine site through anchoring substituents properly adapted to their pocket by a semi-flexible linker.
Maklad RM; AbdelHafez EMN; Abdelhamid D; Aly OM
Bioorg Chem; 2020 Jun; 99():103767. PubMed ID: 32325332
[TBL] [Abstract][Full Text] [Related]
27. Development of [1,2]oxazoloisoindoles tubulin polymerization inhibitors: Further chemical modifications and potential therapeutic effects against lymphomas.
Barreca M; Spanò V; Rocca R; Bivacqua R; Abel AC; Maruca A; Montalbano A; Raimondi MV; Tarantelli C; Gaudio E; Cascione L; Rinaldi A; Bai R; Steinmetz MO; Prota AE; Alcaro S; Hamel E; Bertoni F; Barraja P
Eur J Med Chem; 2022 Dec; 243():114744. PubMed ID: 36242921
[TBL] [Abstract][Full Text] [Related]
28. Design and synthesis of novel 3-amino-5-phenylpyrazole derivatives as tubulin polymerization inhibitors targeting the colchicine-binding site.
Yang Y; Cao Y; Yu J; Yu X; Guo Y; Wang F; Ren Q; Li C
Eur J Med Chem; 2024 Mar; 267():116177. PubMed ID: 38280356
[TBL] [Abstract][Full Text] [Related]
29. Design, synthesis, and biological evaluation of novel diphenylamine derivatives as tubulin polymerization inhibitors targeting the colchicine binding site.
Yan XY; Leng JF; Chen TT; Zhao YJ; Kong LY; Yin Y
Eur J Med Chem; 2022 Jul; 237():114372. PubMed ID: 35447432
[TBL] [Abstract][Full Text] [Related]
30. Combretastatin A-4 sulfur-containing heterocyclic derivatives: Synthesis, antiproliferative activities and molecular docking studies.
Faouzi A; Arnaud A; Bancet A; Barette C; Preto J; Do CV; Jordheim LP; Bousfiha Z; Nguyen TTB; Verrière M; Farce A; Fauvarque MO; Barret R; Lomberget T
Eur J Med Chem; 2021 Apr; 215():113275. PubMed ID: 33618157
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and Biological Evaluation of 2-Methyl-4,5-Disubstituted Oxazoles as a Novel Class of Highly Potent Antitubulin Agents.
Romagnoli R; Baraldi PG; Prencipe F; Oliva P; Baraldi S; Salvador MK; Lopez-Cara LC; Brancale A; Ferla S; Hamel E; Ronca R; Bortolozzi R; Mariotto E; Porcù E; Basso G; Viola G
Sci Rep; 2017 Apr; 7():46356. PubMed ID: 28406191
[TBL] [Abstract][Full Text] [Related]
32. Design, synthesis, biological evaluation, and molecular docking of new benzofuran and indole derivatives as tubulin polymerization inhibitors.
El-Sayed NF; El-Hussieny M; Ewies EF; El Shehry MF; Awad HM; Fouad MA
Drug Dev Res; 2022 Apr; 83(2):485-500. PubMed ID: 34523738
[TBL] [Abstract][Full Text] [Related]
33. Discovery of novel coumarin-indole derivatives as tubulin polymerization inhibitors with potent anti-gastric cancer activities.
Song J; Guan YF; Liu WB; Song CH; Tian XY; Zhu T; Fu XJ; Qi YQ; Zhang SY
Eur J Med Chem; 2022 Aug; 238():114467. PubMed ID: 35605363
[TBL] [Abstract][Full Text] [Related]
34. Synthesis, biological evaluation, and molecular modelling of new naphthalene-chalcone derivatives as potential anticancer agents on MCF-7 breast cancer cells by targeting tubulin colchicine binding site.
Wang G; Liu W; Gong Z; Huang Y; Li Y; Peng Z
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):139-144. PubMed ID: 31724435
[TBL] [Abstract][Full Text] [Related]
35. Tubulin inhibitory activity of a novel colchicine-binding compounds based on a dinaphthospiropyranran scaffold.
Sundriyal S; Eeda V; Lagisetty P; Awasthi V
Bioorg Med Chem; 2021 Jan; 29():115874. PubMed ID: 33223461
[TBL] [Abstract][Full Text] [Related]
36. Synthesis of N-acyl Derivatives of Aminocombretastatin A-4 and Study of their Interaction with Tubulin and Downregulation of c-Myc.
Agut R; Falomir E; Murga J; Martín-Beltrán C; Gil-Edo R; Pla A; Carda M; Díaz JF; Josa-Prado F; Marco JA
Med Chem; 2021; 17(10):1129-1139. PubMed ID: 33222678
[TBL] [Abstract][Full Text] [Related]
37. Identification and optimization of biphenyl derivatives as novel tubulin inhibitors targeting colchicine-binding site overcoming multidrug resistance.
Cheng B; Zhu G; Meng L; Wu G; Chen Q; Ma S
Eur J Med Chem; 2022 Jan; 228():113930. PubMed ID: 34794817
[TBL] [Abstract][Full Text] [Related]
38. Design, synthesis and bioevaluation of novel trifluoromethylquinoline derivatives as tubulin polymerization inhibitors.
Zhang S; Mo M; Lv M; Xia W; Liu K; Yu G; Yu J; Xu G; Zeng X; Cheng S; Xu B; Luo H; Meng X
Future Med Chem; 2023 Nov; 15(21):1967-1986. PubMed ID: 37937524
[No Abstract] [Full Text] [Related]
39. Synthesis, anticancer activity and molecular docking studies on a series of heterocyclic trans-cyanocombretastatin analogues as antitubulin agents.
Penthala NR; Zong H; Ketkar A; Madadi NR; Janganati V; Eoff RL; Guzman ML; Crooks PA
Eur J Med Chem; 2015 Mar; 92():212-20. PubMed ID: 25557492
[TBL] [Abstract][Full Text] [Related]
40. Design, synthesis and biological evaluation of novel thiazole-naphthalene derivatives as potential anticancer agents and tubulin polymerisation inhibitors.
Wang G; Liu W; Fan M; He M; Li Y; Peng Z
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):1694-1702. PubMed ID: 34309466
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
